Drug Shortage Report for SUPREFACT

Last updated on 2017-07-06 History
Report ID 10149
Drug Identification Number 02225166
Brand name SUPREFACT
Common or Proper name Suprefact Inj. M.D. 1mg/ml - vials
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) BUSERELIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2 X 5.5ml
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2017-05-15
Estimated end date 2017-06-09
Actual end date 2017-06-05
Shortage status Resolved
Updated date 2017-07-06
Company comments Manufacturing Delay
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-07-06 English Compare
v7 2017-06-06 French Compare
v6 2017-06-06 English Compare
v5 2017-05-16 English Compare
v4 2017-05-15 French Compare
v3 2017-05-15 English Compare
v2 2017-05-12 French Compare
v1 2017-05-12 English Compare

Showing 1 to 8 of 8